The Food and Drug Administration (FDA) has extended the review period for elinzanetant, an investigational hormone-free therapy for the treatment of moderate to severe vasomotor symptoms (VMS) due to ...

Shares of GSK fell to below $30 around the time of the demerger, but have since recovered to about $36. The 20% gain over 34 ...

Bayer announced an FDA review extension for Elinzanetant, its experimental menopausal hot flash therapy. Approval remains on track. REad more here.

Bayer said the Food and Drug Administration extended the review period for its new drug application of elinzanetant, a treatment for moderate to severe vasomotor symptoms, also known as hot flashes, ...

European regulators on Friday said that the Duchenne muscular dystrophy gene therapy Elevidys should not be approved ...

Last week, an FDA advisory committee against the risk-benefit profile of Blenrep in combination with other therapies. Regulators and reviewers were concerned about the ocular side effects and dosing ...

London: GSK plc has announced the extension of the US Food and Drug Administration (FDA) review period for the Biologics ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

The Kansas City Chiefs had a strong offense with the 2025 NFL Draft, but how does NFL analyst Seth Walder view the Chiefs' offseason success?

The Golden Knights signed defenseman Kaedan Korczak, who is expected to take on a larger role next season, to a four-year extension Wednesday.

New Hampshire’s congressional delegation Friday, June27, announced nearly $925,000 in federal funding to the New Hampshire Manufacturing Extension Partnership, saving it from closure. The NH MEP will ...

An 84-game season is coming to the NHL as part of an extension of the collective bargaining agreement that has been tentatively agreed to by the league and the Players’ Association. They ...